Industry Focus

Latest Episodes:

CG: Blue Apron Becomes the Latest Unicorn to Pursue an IPO Jun 06, 2017

Show notes

In its last private funding round, Blue Apron reached a valuation of over $2 billion. Now, the company has its sights set on the public market, and we are digging into the IPO filing to break down the financials and business model of meal kit delivery for investors.

Financials: The Citizens Financial Turnaround Story Jun 05, 2017

Show notes

Citizens Financial became the biggest bank stock IPO in history when it went public in 2014. Since then, it's orchestrated an impressive turnaround. Sponsored link: http://www.casper.com/fool code fool.

Tech: Wait, What About Mobile Games? Jun 02, 2017

Show notes

Last week we showered Activision, Take-Two, and EA with love, but what about pure-play mobile game publishers like Zynga and Glu Mobile? Do they deserve a spot on your watch list?

Thanks to Bombfell for supporting The Motley Fool. Get $25 off your first purchase at http://bombfell.com/fool

Energy: Trump Turns Off the Lights On Paris Jun 01, 2017

Show notes

Donald Trump is likely to pull the US out of the Paris Climate Agreement – here’s what it means.

Thanks to Bombfell for supporting The Motley Fool. Get $25 off your first purchase at http://bombfell.com/fool

Healthcare: Is "Sell In May And Go Away" Good Advice? May 31, 2017

Show notes

Summer may not be the best time to own stocks historically, but embracing this old Wall Street adage is far from risk-less.

CG: The M&A Rumor Mill May 30, 2017

Show notes

We look at major acquisition talks making headlines this week as American Eagle pursues its apparel rival Abercrombie & Fitch, and Kraft-Heinz eyes a mega-deal with Colgate-Palmolive.

Industry Focus: Behind the Curtain May 29, 2017

Show notes

Have you ever wondered what the Industry Focus cast is like in real life? This episode gives you a glimpse.

Tech: Video Game Stocks Set New High Scores May 26, 2017

Show notes

Game publishers Activision, Take-Two, and Electronic Arts have all soared so far in 2017. With all three up over 40% year-to-date, is it too late for investors to hop in and play?

Energy: OPEC extends production cuts: desperation or brilliance? May 25, 2017

Show notes

OPEC extended its production cut for another 9 months, could this be a desperate move by a powerless cartel?

Healthcare: Thalidomide's Present-Day Legacy May 24, 2017

Show notes

Extreme birth defects associated with a popular anti-anxiety medicine from the 1960's had a lasting impact on today's healthcare policy -- and the drug is still a major part of Celgene's cancer portfolio.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected